drugset / Trial / NCT04921943
Hypertonic Saline for MAC
Phase 4
Recruiting
50 enrolled
Oregon Health and Science University
NTM Info & Research, Inc. · collabNew York University · collabUniversity Health Network, Toronto · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The MAC-HS study is a testing whether hypertonic saline helps improve symptoms and clearance of mycobacteria in patients with M. avium complex lung infections.
Timeline
- Start
- 2021-05-18
- Primary completion
- 2025-12-31
- Completion
- 2025-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Hypertonic saline | Unknown | 3 % | Inhaled |
| Subject | Hypertonic saline | Unknown | 7 % | Inhaled |
| Comparator | Azithromycin | Small molecule | — | — |
| Comparator | Ethambutol | Small molecule | — | — |
| Comparator | Rifampin | Small molecule | — | — |